Relationship between thyroid nodules and non-functioning adrenal incidentalomas and their association with insulin resistance

References

• Burguera B, Gharib H. Thyroid incidentalomas. Prevalence, diagnosis, significance and management. Endocrinol Metab Clin North Am 2000;29:187–203
   Google Scholar
• Mortensen JD, Woolner LB, Bennett WA. Gross and microscopic findings in clinically normal thyroid glands. J Clin Endocrinol Metab 1955;15:1270–80
   PubMed Web of Science ®Google Scholar
• Reiners C, Wegscheider K, Schicha H, et al. Prevalence of thyroid disorders in the working population of Germany: ultrasonography screening in 96,278 unselected employees. Thyroid 2004;14:926–32
   PubMed Web of Science ®Google Scholar
• Tan GH, Gharib H. Thyroid incidentalomas. Management approaches to nonpalpable nodules discovered incidentally on thyroid imaging. Ann Intern Med 1997;126:226–31
   PubMed Web of Science ®Google Scholar
• Mannsman G, Lau J, Balk E, et al. The clinically inapparent adrenal mass: update in diagnosis and management. Endocr Rev 2004;25:309–40
   Google Scholar
• Kloss RT, Gross MD, Francis IR, et al. Incidentally discovered adrenal masses. Endocr Rev 1995;16:460–84
   Google Scholar
• Glazer HS, Weyman PJ, Sagel SS, et al. Non functioning adrenal masses:incidental discovery on computed tomography. Am J Roentgenal 1982;139:81–5
   PubMed Web of Science ®Google Scholar
• Sington JD, Syn WK, Suvarna SK, et al. Lack of association between thyroid and adrenal nodules: a histological study. J Endocrinol Invest 1999;22:262–5
   Google Scholar
• Terzolo M, Pia A, Alì A, et al. Adrenal incidentaloma: a new cause of the metabolic syndrome? J Clin Endocrinol Metab 2002;87:998–1003
   PubMed Web of Science ®Google Scholar
• Ayturk S, Gursoy A, Kut A, et al. Metabolic syndrome and its components are associated with increased thyroid volume and nodule prevalence in a mild-to-moderate iodine-deficient area. Eur J Endocrinol 2009;161:599–605
   PubMed Web of Science ®Google Scholar
• Zeiger MA, Thompson GB, Duh QY, et al. American Association of Clinical Endocrinologists; American Association of Endocrine Surgeons. American Association of Clinical Endocrinologists and American Association of Endocrine Surgeons Medical Guidelines for the Management of Adrenal Incidentalomas: executive summary of recommendations. Endocr Pract 2009;15:450–3
   PubMed Web of Science ®Google Scholar
• Expert Panel on the Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation and Treat-ment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 2001;285:2486–97
   PubMed Web of Science ®Google Scholar
• Erdoğan MF, Demir O, Emral R, et al. More than a decade of iodine prophylaxis is needed to eradicate goiter among school age children in a moderately iodine-deficient region. Thyroid 2009;19:265–8
   PubMed Web of Science ®Google Scholar
• Brunn J, Block U, Ruf G, et al. Volumetric analysis of thyroid lobes by real-time ultrasound. Deutsche Medizinische Wochenschrift 1981;106:1338–40
   PubMed Web of Science ®Google Scholar
• Young WF Jr. Clinical practice. The incidentally discovered adrenal mass. N Engl J Med 2007;356:601–10
   PubMed Web of Science ®Google Scholar
• Mantero F, Terzolo M, Arnaldi G, et al. A survey on adrenal incidentaloma in Italy. J Clin Endocrinol Metab 2000;85:637–44
   PubMed Web of Science ®Google Scholar
• Juarez-Lopez C, Klunder-Klunder M, Medina-Bravo P, et al. Insulin resistance and its association with the components of metabolic syndrome among obese children and adolescents. BMC Public Health 2010;10:318
   PubMed Web of Science ®Google Scholar
• Satman I, Omer B, Tutuncu Y, et al. Twelve-year trends in the prevalence and risk factors of diabetes and prediabetes in Turkish adults. Eur J Epidemiol 2013;28:169–80
   PubMed Web of Science ®Google Scholar
• Garrapa GG, Pantanetti P, Arnaldi G, et al. Body composition and metabolic features in women with adrenal incidentaloma or Cushing’s syndrome. J Clin Endocrinol Metab 2001;86:5301–6
   Google Scholar
• Kimura T, Van Keymeulen A, Golstein J, et al. Regulation of thyroid cell proliferation by TSH and other factors: a critical evaluation of in vitro models. Endocr Rev 2001;22:631–56
   PubMed Web of Science ®Google Scholar
• Rezzonico J, Rezzonico M, Pusiol E, et al. Introducing the thyroid gland as another victim of the insulin resistance syndrome. Thyroid 2008;18:461–4
   PubMed Web of Science ®Google Scholar
• Dumont JE, Lamy F, Roger P, et al. Physiological and pathological regulation of thyroid cell proliferation and differentiation by thyrotropin and other factors. Physiol Rev 1992;72:667–97
   PubMed Web of Science ®Google Scholar
• Michalaki MA, Vagenakis AG, Leonardou AS, et al. Thyroid function in humans with morbid obesity. Thyroid 2006;16:73–8
   PubMed Web of Science ®Google Scholar
• Sari R, Balci MK, Altunbas H, et al. The effect of body weight and weight loss on thyroid volume and function in obese women. Clin Endocrinol (Oxf) 2003;59:258–62
   PubMed Web of Science ®Google Scholar
• Rendina D, De Filippo G, Mossetti G, et al. Relationship between metabolic syndrome and multinodular non-toxic goiter in an inpatient population from a geographic area with moderate iodine deficiency. J Endocrinol Invest 2012;35:407–12
   PubMed Web of Science ®Google Scholar
• Liu YJ, Qiang W, Liu XJ, et al. Association of insulin-like growth factor-1 with thyroid nodules. Oncol Lett 2011;2:1297–301
   Google Scholar
• Völzke H, Friedrich N, Schipf S, et al. Association between serum insulin-like growth factor-I levels and thyroid disorders in a population-based study. J Clin Endocrinol Metab 2007;92:4039–45
   Google Scholar
• Hsiao PJ, Tsai JH. Increased insulin-like growth factor-1 receptors in thyroid tissues of Graves’ disease. J Formos Med Assoc 1994;93:925–32
   Google Scholar